We are live on ! Find out more
DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
-1.96%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$114M
AUM Growth
-$29.8M
Cap. Flow
-$27M
Cap. Flow %
-23.68%
Top 10 Hldgs %
42.25%
Holding
85
New
11
Increased
13
Reduced
16
Closed
19

Top Buys

1
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
+$4.51M
2
IBB icon
iShares Biotechnology ETF
IBB
+$2.38M
3
BPMC
Blueprint Medicines
BPMC
+$2.19M
4
CDTX
Cidara Therapeutics
CDTX
+$1.66M
5
ADXS
Advaxis Inc
ADXS
+$1.57M

Top Sells

1
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
+$15M
2
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
+$9.26M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$2.15M
4
BSTC
BioSpecifics Technologies Corp.
BSTC
+$1.81M
5
TSRO
TESARO, Inc.
TSRO
+$1.77M

Sector Composition

1 Healthcare 81.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATRC icon
1
AtriCure
ATRC
$1.75B
$10.2M 8.92%
518,946
-10,000
-2% -$181K
NXTM
2
DELISTED
NxStage Medical Inc.
NXTM
$6.19M 5.44%
236,119
-2,390
-1% -$59.1K
ALDR
3
DELISTED
Alder Biopharmaceuticals
ALDR
$4.6M 4.04%
221,013
+55,700
+34% +$1.45M
LOXO
4
DELISTED
Loxo Oncology, Inc
LOXO
$4.49M 3.94%
139,722
+9,500
+7% +$244K
LKFT
5
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
$4.24M 3.73%
66,068
– –
VIRX
6
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.1M 3.61%
+32,388
New +$4.51M
XENE icon
7
Xenon Pharmaceuticals
XENE
$6.55B
$3.96M 3.48%
514,091
– –
AERI
8
DELISTED
Aerie Pharmaceuticals
AERI
$3.72M 3.27%
98,370
+6,501
+7% +$246K
ONC
9
BeOne Medicines Ltd
ONC
$32.3B
$3.64M 3.2%
119,841
+29,699
+33% +$933K
DERM
10
DELISTED
Dermira, Inc.
DERM
$3M 2.63%
98,800
– –
FOMX
11
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$2.98M 2.61%
268,067
-10,000
-4% -$94.1K
PODD icon
12
Insulet
PODD
$11B
$2.77M 2.43%
73,484
– –
AGTC
13
DELISTED
Applied Genetic Technologies Corporation
AGTC
$2.68M 2.35%
286,298
+46,000
+19% +$414K
CYTK icon
14
Cytokinetics
CYTK
$11.2B
$2.56M 2.24%
210,306
+28,569
+16% +$303K
NBIX icon
15
Neurocrine Biosciences
NBIX
$17.3B
$2.56M 2.24%
66,008
+2,000
+3% +$90.5K
ARDX icon
16
Ardelyx
ARDX
$1.31B
$2.47M 2.17%
173,995
-45,100
-21% -$640K
IBB icon
17
iShares Biotechnology ETF
IBB
$9.24B
$2.31M 2.03%
+26,100
New +$2.38M
TSRO
18
DELISTED
TESARO, Inc.
TSRO
$2.08M 1.83%
15,500
-14,000
-47% -$1.77M
IMMU
19
DELISTED
Immunomedics Inc
IMMU
$2.05M 1.8%
559,674
-7,122
-1% -$21.1K
RDUS
20
DELISTED
Radius Health, Inc.
RDUS
$2.05M 1.8%
53,854
+17,000
+46% +$809K
BPMC
21
DELISTED
Blueprint Medicines
BPMC
$2.03M 1.79%
+72,500
New +$2.19M
TVRD
22
Tvardi Therapeutics
TVRD
$27.5M
$1.95M 1.71%
5,820
-1,598
-22% -$513K
DSCI
23
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$1.84M 1.62%
353,718
– –
MGNX icon
24
MacroGenics
MGNX
$275M
$1.82M 1.6%
89,200
+35,000
+65% +$881K
BEAT
25
DELISTED
BioTelemetry, Inc.
BEAT
$1.68M 1.47%
75,000
-5,000
-6% -$97.8K
1
2 3 4

Similar funds

FGWP
Founders Grove Wealth Partners Richmond, Virginia $440M AUM 16.56% 1-Year Est. Return
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $439M AUM 10.15% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
AWM
Austin Wealth Management Austin, Texas $440M AUM 17.66% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $440M AUM